Vistagen to present at jefferies 2023 global healthcare conference

South san francisco, calif.--(business wire)---- $vtgn #mentalhealth--vistagen (nasdaq: vtgn), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (cns) disorders, today announced that its chief executive officer, shawn singh, will present and host one-on-one meetings at the jefferies global healthcare conference taking place june 7 – 9, 2023 in new york city, ny. jefferies 2023 global healthcare co.
VTGN Ratings Summary
VTGN Quant Ranking